Results 191 to 200 of about 42,119 (250)

Pharmacological rhythm control strategy and outcomes in the oldest atrial fibrillation patients: an analysis of the nationwide Italian START registry. [PDF]

Age Ageing
Menichelli D, Gazzaniga G, Poli D, Di Carlo G, Antonucci E, Violi F, Pignatelli P, Pastori D.   +7 more
europepmc   +1 more source

Short QT Syndrome Masquerading as Lone Atrial Fibrillation: Hidden in Plain Sight. [PDF]

JACC Case Rep
Yoo TK, Trujillo-Arvizu L, Kaufman C, Pendela VS, Rodriguez S, Hu T, Tugal D, Helm RH, Monahan KM.   +8 more
europepmc   +1 more source

Transitioning Amiodarone Tablet Manufacturing: A Comparative Study of Batch and Continuous Wet Granulation. [PDF]

Pharmaceuticals (Basel)
Yoon JH, Jeon CW, Kim JE.
europepmc   +1 more source

When Rhythm Control Backfires: A Case of Severe QT Prolongation and Polymorphic Ventricular Tachycardia Following Dual Antiarrhythmic Therapy. [PDF]

Cureus
Sapkota S, Balasubramanian A, Vishakh P, Ruck L, Siddiqui T.   +4 more
europepmc   +1 more source

A varying presentation of refractory supra ventricular tachycardia in a newborn: A rare and unusual case report. [PDF]

J Family Med Prim Care
Rawat A, Lakra MS, Karotkar SAR, Lakhkar B, Taksande A.   +4 more
europepmc   +1 more source

A case of new onset of atrial fibrillation during thoracoscopic lobectomy and review of the literature. [PDF]

J Cardiothorac Surg
Zuo Y, Yang Y, Liang G, Wei Z, Wu X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Amiodarone and the thyroid

American Journal of Medicine, 2005
Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended ...
David Cooper, Shehzad Basaria
exaly   +3 more sources